Association of CRP/albumin ratio with no-reflow in NSTEMI
Troia Medical Journal · 31.05.2026 · 7 (2) · 70-76
DOI: 10.55665/troiamedj.1824706 ↗Kurz gefasst
Fachartikel in der Zeitschrift Troia Medical Journal, online erschienen am 31.05.2026. Verfasst von Muhammet Cihat Çelik und 5 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Objective
This study examined the predictive value of the high-sensitivity C-reactive protein/albumin ratio (CAR) for angiographic no-reflow in NSTEMI patients undergoing PCI.
Methods
We retrospectively evaluated 400 NSTEMI patients treated with PCI between 2021 and 2023. Patients were classified by post-procedural TIMI flow: no-reflow (TIMI ≤2) or normal reflow (TIMI 3). Clinical, laboratory, and angiographic variables were compared. Logistic regression identified independent predictors, and ROC analysis assessed CAR’s discriminative ability.
Results
No-reflow occurred in 45 patients (11.3%). Compared with normal reflow, the no-reflow group had higher hs-CRP, lower albumin, and thus elevated CAR (median 0.27 vs. 0.13, p
Zitieren
APA
Çelik, M. C., Kalçık, M., Dolu, A. K., Karayiğit, O., Yetim, M., & Bekar, L. (2026). Association of CRP/albumin ratio with no-reflow in NSTEMI. Troia Medical Journal, 7(2), 70-76. https://doi.org/10.55665/troiamedj.1824706
Vancouver
Çelik MC, Kalçık M, Dolu AK, Karayiğit O, Yetim M, Bekar L. Association of CRP/albumin ratio with no-reflow in NSTEMI. Troia Medical Journal. 2026;7(2):70-76. doi:10.55665/troiamedj.1824706
BibTeX
@article{elik2026,
author = {Çelik, Muhammet Cihat and Kalçık, Macit and Dolu, Abdullah Kadir and Karayiğit, Orhan and Yetim, Mucahit and Bekar, Lütfü},
title = {Association of CRP/albumin ratio with no-reflow in NSTEMI},
journal = {Troia Medical Journal},
year = {2026},
volume = {7},
number = {2},
pages = {70--76},
doi = {10.55665/troiamedj.1824706}
}
EUVIMED